Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women

Journal of Bone and Mineral Research

Volumn 22, Issue 1, 2007, Pages 127-134

  Gerdhem, Paul ^a,c   Ivaska, Kaisa K ^a,b   Isaksson, Anders ^a   Pettersson, Kim ^b   Väänänen, H Kalervo ^b   Obrant, Karl J ^a   Åkesson, Kristina ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aging; BMD; Bone metabolic markers; Bone ultrasound; Folate; Fracture; Homocysteine; Mortality; Population studies; Vitamin B12

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGEN TYPE 1; CYANOCOBALAMIN; DEOXYPYRIDINOLINE; FOLIC ACID; HOMOCYSTEINE; OSTEOCALCIN; PARATHYROID HORMONE; TARTRATE RESISTANT ACID PHOSPHATASE ISOFORM 5B; TYPE 1 COLLAGEN CROSS LINKING TELOPEPTIDE; UNCLASSIFIED DRUG;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCANEUS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOGRAPHY; ENERGY; FEMALE; FOLLOW UP; FRACTURE; GAIT; HIP; HIP FRACTURE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MORTALITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SWEDEN; TASK PERFORMANCE; URINE LEVEL; WALKING SPEED;

AGED; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HOMOCYSTEINE; HUMANS; QUESTIONNAIRES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33845919859     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.061003     Document Type: Article

References (47)

1. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lips P, Smit JH, van Staveren WA 2005 Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 20:921-929.
2. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP 2004 Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 350:2042-2049.
3. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG 2004 Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2033-2041.
4. Sato Y, Iwamoto J, Kanoko T, Satoh K 2005 Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med 118:1250-1255.
5. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer L 1985 The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1-31.
6. Whiting SJ, Draper HH 1981 Effect of a chronic acid load as sulfate or sulfur amino acids on bone metabolism in adult rats. J Nutr 111:1721- 1726.
7. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH 1996 Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159-162.
8. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W 2005 Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and postmenopausal women. Clin Chem Lab Med 43:1118-1123.
9. Nilsson K, Gustafson L, Isaksson A, Hultberg B 2005 Plasma homocysteine and markers of bone metabolism in psychogeriatric patients. Scand J Clin Lab Invest 65:671-680.
10. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W 2005 Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 51:2348-2353.
11. Sakamoto W, Isomura H, Fujie K, Deyama Y, Kato A, Nishihira J, Izumi H 2005 Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC3T3-E1 preosteoblastic cells. Biochim Biophys Acta 1740:12-16.
12. Raisz LG 2004 Homocysteine and osteoporotic fractures- culprit or bystander? N Engl J Med 350:2089-2090.
13. Ravaglia G, Forti P, Maioli F, Servadei L, Martelli M, Brunetti N, Bastagli L, Cucinotta D, Mariani E 2005 Folate, but not homocysteine, predicts the risk of fracture in elderly persons. J Gerontol A Biol Sci Med Sci 60:1458-1462.
14. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K 2005 Effect of folate and mecobalamin on hip fractures in patients with stroke: A randomized controlled trial. JAMA 293:1082-1088.
15. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR 2004 Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: A cross-sectional study. Bone 35:760-765.
16. Morris MS, Jacques PF, Selhub J 2005 Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 37:234-242.
17. Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, Pettersson K, Vaananen HK, Akesson K, Obrant KJ 2004 Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 19:386-393.
18. Obrant KJ, Ivaska KK, Gerdhem P, Alatalo SL, Pettersson K, Vaananen HK 2005 Biochemical markers of bone turnover are influenced by recently sustained fracture. Bone 36:786-792.
19. Gerdhem P, Isaksson A, Akesson K, Obrant KJ 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506-1512.
20. Andersson A, Isaksson A, Brattstrom L, Hultberg B 1993 Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 39:1590-1597.
21. Nilsson K, Gustafson L, Faldt R, Andersson A, Hultberg B 1994 Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population. Eur J Clin Invest 24:600-606.
22. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vaananen HK 2000 Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption. J Bone Miner Res 15:1337-1345.
23. Käkönen SM, Hellman J, Karp M, Laaksonen P, Obrant KJ, Vaananen HK, Lovgren T, Pettersson K 2000 Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin Chem 46:332-337.
24. Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K 2005 Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int 16:1425-1431.
25. Gerdhem P, Ringsberg KA, Akesson K, Obrant KJ 2005 Clinical history and biologic age predicted falls better than objective functional tests. J Clin Epidemiol 58:226-232.
26. Ringsberg K, Gerdhem P, Johansson J, Obrant KJ 1999 Is there a relationship between balance, gait performance and muscular strength in 75-year-old women? Age Ageing 28:289-293.
27. Franchignoni F, Tesio L, Martino MT, Ricupero C 1998 Reliability of four simple, quantitative tests of balance and mobility in healthy elderly females. Aging (Milano) 10:26-31.
28. Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C1996 Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up study. Bone 19:9-12.
29. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res 11:1531-1538.
30. Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gardsell P, Obrant KJ 1995 Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women. J Bone Miner Res 10:1823-1829.
31. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD 2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15:1526-1536.
32. Garnero P 2000 Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 11(Suppl 6):S55-S65.
33. Nenonen A, Cheng S, Ivaska KK, Alatalo SL, Lehtimaki T, Schmidt-Gayk H, Uusi-Rasi K, Heinonen A, Kannus P, Sievanen H, Vuori I, Vaananen HK, Halleen JM 2005 Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone Turnover. J Bone Miner Res 20:1804-1812.
34. Janckila AJ, Takahashi K, Sun SZ, Yam LT 2001 Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47:74-80.
35. Tucker KL, Hannan MT, Qiao N, Jacques PF, Selhub J, Cupples LA, Kiel DP 2005 Low plasma vitamin B12 is associated with lower BMD: The Framingham Osteoporosis Study. J Bone Miner Res 20:152-158.
36. Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A 2003 Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 33:956-959.
37. Espallargues M, Sampietro-Colom L, Estrada MD, Sola M, del Rio L, Setoain J, Granados A 2001 Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: A systematic review of the literature. Osteoporos Int 12:811-822.
38. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, Breart G 1996 Fall-related factors and risk of hip fracture: The EPIDOS prospective study. Lancet 348:145-149.
39. Kado DM, Bucur A, Selhub J, Rowe JW, Seeman T 2002 Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. Am J Med 113:537-542.
40. 2006 Statistical Yearbook of Sweden, vol. 92. Available at http://www.scb.se. Accessed May 15, 2006.
41. Jonsson B, Gardsell P, Johnell O, Redlund-Johnell I, Sernbo I 1994 Remembering fractures: Fracture registration and proband recall in southern Sweden. J Epidemiol Community Health 48:489-490.
42. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM 1994 Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 124:1934-1941.
43. Guttormsen AB, Solheim E, Refsum H 2004 Variation in plasma cystathionine and its relation to changes in plasma concentrations of homocysteine and methionine in healthy subjects during a 24-h observation period. Am J Clin Nutr 79:76-79.
44. Lavie L, Lavie P 2004 Daily rhythms in plasma levels of homocysteine. J Circadian Rhythms 2:5.
45. Fokkema MR, Gilissen MF, Van Doormaal JJ, Volmer M, Kema IP, Muskiet FA 2003 Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia. Clin Chem 49:818-821.
46. Toole IF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M 2004 Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291:565-575.
47. Nilsson SE, Evrin PE, Tryding N, Berg S, McClearn G, Johansson B 2003 Biochemical values in persons older than 82 years of age: Report from a population-based study of twins. Scand J Clin Lab Invest 63:1-13.